Cargando…

Laropiprant attenuates EP(3) and TP prostanoid receptor-mediated thrombus formation

Detalles Bibliográficos
Autores principales: Philipose, Sonia, Kónya, Viktória, Lazarević, Mirjana, Pasterk, Lisa M, Marsche, Gunther, Frank, Sasa, Peskar, Bernhard A, Heinemann, Ákos, Schuligoi, Rufina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506277/
http://dx.doi.org/10.1186/2050-6511-13-S1-A14
_version_ 1782250879252955136
author Philipose, Sonia
Kónya, Viktória
Lazarević, Mirjana
Pasterk, Lisa M
Marsche, Gunther
Frank, Sasa
Peskar, Bernhard A
Heinemann, Ákos
Schuligoi, Rufina
author_facet Philipose, Sonia
Kónya, Viktória
Lazarević, Mirjana
Pasterk, Lisa M
Marsche, Gunther
Frank, Sasa
Peskar, Bernhard A
Heinemann, Ákos
Schuligoi, Rufina
author_sort Philipose, Sonia
collection PubMed
description
format Online
Article
Text
id pubmed-3506277
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35062772012-11-29 Laropiprant attenuates EP(3) and TP prostanoid receptor-mediated thrombus formation Philipose, Sonia Kónya, Viktória Lazarević, Mirjana Pasterk, Lisa M Marsche, Gunther Frank, Sasa Peskar, Bernhard A Heinemann, Ákos Schuligoi, Rufina BMC Pharmacol Toxicol Meeting Abstract BioMed Central 2012-09-17 /pmc/articles/PMC3506277/ http://dx.doi.org/10.1186/2050-6511-13-S1-A14 Text en Copyright ©2012 Philipose et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Philipose, Sonia
Kónya, Viktória
Lazarević, Mirjana
Pasterk, Lisa M
Marsche, Gunther
Frank, Sasa
Peskar, Bernhard A
Heinemann, Ákos
Schuligoi, Rufina
Laropiprant attenuates EP(3) and TP prostanoid receptor-mediated thrombus formation
title Laropiprant attenuates EP(3) and TP prostanoid receptor-mediated thrombus formation
title_full Laropiprant attenuates EP(3) and TP prostanoid receptor-mediated thrombus formation
title_fullStr Laropiprant attenuates EP(3) and TP prostanoid receptor-mediated thrombus formation
title_full_unstemmed Laropiprant attenuates EP(3) and TP prostanoid receptor-mediated thrombus formation
title_short Laropiprant attenuates EP(3) and TP prostanoid receptor-mediated thrombus formation
title_sort laropiprant attenuates ep(3) and tp prostanoid receptor-mediated thrombus formation
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506277/
http://dx.doi.org/10.1186/2050-6511-13-S1-A14
work_keys_str_mv AT philiposesonia laropiprantattenuatesep3andtpprostanoidreceptormediatedthrombusformation
AT konyaviktoria laropiprantattenuatesep3andtpprostanoidreceptormediatedthrombusformation
AT lazarevicmirjana laropiprantattenuatesep3andtpprostanoidreceptormediatedthrombusformation
AT pasterklisam laropiprantattenuatesep3andtpprostanoidreceptormediatedthrombusformation
AT marschegunther laropiprantattenuatesep3andtpprostanoidreceptormediatedthrombusformation
AT franksasa laropiprantattenuatesep3andtpprostanoidreceptormediatedthrombusformation
AT peskarbernharda laropiprantattenuatesep3andtpprostanoidreceptormediatedthrombusformation
AT heinemannakos laropiprantattenuatesep3andtpprostanoidreceptormediatedthrombusformation
AT schuligoirufina laropiprantattenuatesep3andtpprostanoidreceptormediatedthrombusformation